IPP Bureau

Funds for R&D in drug discovery and manufacturing :PIB
Funds for R&D in drug discovery and manufacturing :PIB

By IPP Bureau - July 26, 2022

An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.

Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin

By IPP Bureau - July 25, 2022

Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.

WuXi STA opens a new large scale continuous manufacturing plant at Changzhou site
WuXi STA opens a new large scale continuous manufacturing plant at Changzhou site

By IPP Bureau - July 24, 2022

WuXi STA opens a new large scale continuous manufacturing plant

WuXi AppTec plans to build a new site in Singapore
WuXi AppTec plans to build a new site in Singapore

By IPP Bureau - July 24, 2022

Better serving global partners and advancing healthcare innovation

FDA approval of deep brain stimulators will drive APAC market, says GlobalData
FDA approval of deep brain stimulators will drive APAC market, says GlobalData

By IPP Bureau - July 24, 2022

Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression

Import of Medical Devices Up by Record 41% in FY22: AiMeD
Import of Medical Devices Up by Record 41% in FY22: AiMeD

By IPP Bureau - July 24, 2022

India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21

Merck opens microbiology application lab in Jigani, Bengaluru
Merck opens microbiology application lab in Jigani, Bengaluru

By IPP Bureau - July 24, 2022

Merck’s first microbiology application and training lab in India

SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM

By IPP Bureau - July 24, 2022

With this, the company can start selling Ibuprofen in the European markets.

Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market

By IPP Bureau - July 24, 2022

Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.

DS-7300 Phase 2 Trial Initiated in Patients with Pretreated ExtensiveStage Small Cell Lung Cancer
DS-7300 Phase 2 Trial Initiated in Patients with Pretreated ExtensiveStage Small Cell Lung Cancer

By IPP Bureau - July 21, 2022

DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate

Syngene reports revenue from operations up 8% in Q1 FY 23
Syngene reports revenue from operations up 8% in Q1 FY 23

By IPP Bureau - July 21, 2022

Company raises the annual revenue guidance from mid-teens to high teens

Merck updates on Phase 3 Keynote-412 trial in advanced head and neck squamous cell carcinoma
Merck updates on Phase 3 Keynote-412 trial in advanced head and neck squamous cell carcinoma

By IPP Bureau - July 21, 2022

India’s first 4th Gen transcatheter mitral valve performed at Apollo Chennai
India’s first 4th Gen transcatheter mitral valve performed at Apollo Chennai

By IPP Bureau - July 21, 2022

Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs

Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round
Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round

By IPP Bureau - July 20, 2022

The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product

Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease
Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease

By IPP Bureau - July 20, 2022

The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.

Latest Stories

Interviews

Packaging